中国药物经济学2024,Vol.19Issue(7) :113-116.DOI:10.12010/j.issn.1673-5846.2024.07.024

企业新药研发的风险控制策略

Analysis of Risk Control Strategy of New Drug Research and Development in Enterprises

吴旭璇 黄哲
中国药物经济学2024,Vol.19Issue(7) :113-116.DOI:10.12010/j.issn.1673-5846.2024.07.024

企业新药研发的风险控制策略

Analysis of Risk Control Strategy of New Drug Research and Development in Enterprises

吴旭璇 1黄哲1
扫码查看

作者信息

  • 1. 沈阳药科大学,沈阳 110000
  • 折叠

摘要

新药研发项目存在着多种风险,包括市场风险、技术风险、法规与合规风险、财务风险.在应对这些风险时,研发团队应采取一系列策略.加强市场调研、需求预测、竞争分析降低市场风险;建立科学技术评估体系应对技术风险;遵守法规与合规要求减少法规风险;建立稳健财务管理体系可以应对财务风险.只有通过合理的风险规避和管理策略,新药研发项目才能取得成功并为社会带来更多的医疗福祉.

Abstract

There are many risks in new drug research and development projects,including market risk,technical risk,regulatory and compliance risk,and financial risk.In dealing with these risks,R&D teams should adopt a range of strategies.Strengthen market research,demand forecasting,competition analysis to reduce market risk;Establish a scientific and technological evaluation system to cope with technological risks;Compliance with regulatory and compliance requirements to reduce regulatory risk;The establishment of sound financial management system can deal with financial risks.Only through reasonable risk avoidance and management strategies can new drug development programs succeed and bring more medical benefits to society.

关键词

风险控制/新药研发/响应策略

Key words

Risk control/New drug research and development/Response strategy

引用本文复制引用

出版年

2024
中国药物经济学
中国中医药研究促进会

中国药物经济学

影响因子:0.712
ISSN:1673-5846
段落导航相关论文